ASK REDCHAT ANYTHING ABOUT IRONWOOD PHARMACEUTICALS, INC.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
Listen to this Section
$3.36
-0.0450
(
-1.32% )
624.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Linzess® (linaclotide)DetailsConstipation |
Approved |
| Linzess® (linaclotide)DetailsIrritable bowel syndrome, Inflammatory bowel disease, Bowel disorder |
Approved |
| Apraglutide (agonist of the GLP-2 receptor)DetailsShort bowel syndrome |
Phase 3 |
| Apraglutide (agonist of the GLP-2 receptor)DetailsAcute graft-versus host disease |
Phase 2 |
| IW-3300DetailsEndometriosis, Visceral pain, Interstitial cystitis/bladder pain syndrome |
Phase 2 |
| Apraglutide (agonist of the GLP-2 receptor)DetailsShort bowel syndrome with colon-in-continuity , Short bowel syndrome |
Phase 2 |
| CNP-104DetailsPrimary biliary cholangitis, Liver disease, Autoimmune disease |
Phase 2a |
| LinaclotideDetailsIrritable bowel syndrome, Inflammatory bowel disease, Bowel disorder, Constipation |
Failed |
Market Data
|
| Open |
$3.36 |
| Previous Close |
$3.40 |
| Volume |
624.0K |
| Market Cap |
$533.35M |
| Day Range |
$3.33 - $3.50 |
| 52 Week Range |
$0.56 - $5.78 |
| Shares Outstanding |
164.61M |
| Change % |
-1.32% |
| Net Change |
▼ -0.0450 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Year | 2010 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-1,798,351.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-14 |
Sale |
-3107.00 |
Silver Ronald |
| 2024-08-14 |
Sale |
-9910.00 |
John Minardo |
| 2024-06-21 |
Sale |
-24311.00 |
Dreyfus Andrew |
| 2024-06-21 |
Sale |
-24311.00 |
DENNER ALEXANDER J |
| 2024-06-21 |
Sale |
-24311.00 |
Moukheibir Catherine |
| 2024-06-21 |
Sale |
-24311.00 |
Shepard Jay |
| 2024-06-21 |
Sale |
-24311.00 |
McHugh Julie |
| 2024-06-21 |
Sale |
-24311.00 |
Kessler Marla L |
| 2024-06-21 |
Sale |
-24311.00 |
Duane Jon R |
| 2024-06-21 |
Sale |
-24311.00 |
Currie Mark G |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
83 |
Nov 10, 2025 |
| 8-k |
8K-related |
14 |
Nov 10, 2025 |
| 8-k |
8K-related |
12 |
Oct 10, 2025 |
| 4 |
Insider transactions |
1 |
Sep 17, 2025 |
| 8-k |
8K-related |
12 |
Sep 03, 2025 |
| 4 |
Insider transactions |
2 |
Aug 13, 2025 |
| 4 |
Insider transactions |
1 |
Aug 13, 2025 |
| 4 |
Insider transactions |
1 |
Aug 13, 2025 |
| 4 |
Insider transactions |
1 |
Aug 13, 2025 |
| 10-q |
Quarterly Reports |
81 |
Aug 11, 2025 |